ArticleScientific reports2023

hsa-miR-199b-3p suppresses osteosarcoma progression by targeting CCDC88A, inhibiting epithelial-to-mesenchymal transition, and Wnt/beta-catenin signaling pathway.

Dongsheng Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.